GROUP SITES OUR LABORATORY OUR MEDICINES OUR ENGAGEMENTS USEFUL CONTACTS ABOUT ASPEN OUR PRIORITY IS TO MAKE AVAILABLE ESSENTIAL MEDICINES AT A HIGH LEVEL OF QUALITY, SAFETY, QUANTITY AND AT THE RIGHT PRICE WHILE PROVIDING SCIENTIFIC INFORMATION ESSENTIAL FOR THE CORRECT DIAGNOSIS AND THE GOOD USE OF THE MEDICINAL PRODUCT. FR-NPR-0118-0223 © Aspen France SAS 2021 Legal Notice Privacy Policy Privacy policy - HR application Aspen PAIA & POPI Manual Updated on 09/01/2021

GROUP SITES OUR RESPONSE TO COVID-19 ABOUT ASPEN BUSINESS SEGMENTS INVESTOR RELATIONS WE CARE SUSTAINABILITY GROUP NEWS CAREERS CONTACT US ASPEN TAIWAN On 10 June 2014 Aspen Global’s subsidiary in Taiwan was officially opened. Aspen Healthcare Taiwan Limited (Aspen Taiwan) operates according to a flexible business model to leverage leading international pharmaceutical originator brands and expand on local opportunities in the Taiwan market. Our main therapeutic categories are cardiovascular (particularly anti-coagulants), anaesthesia, immunosuppressant, metabolic diseases, oncolytic, hormonal and localised business opportunities. Aspen Taiwan is devoted to product life cycle management as well as the introduction of niche products to benefit patients in the Taiwanese market. For further assistance click here to send an email or contact us as follows: Aspen Healthcare Taiwan Limited Suite A, 20F, No 207, Sec 2, Dunhua South Rd Taipei City 10602, Taiwan Phone: +886 -2 – 2730 – 3082 Fax: +886 -2 – 2730 – 3098 © 2021 Aspen Holdings Disclaimer Privacy Statement Aspen PAIA & POPI Manual Standard Terms of purchase of goods or services (STC) Contact details Designed & Produced by Bastion Graphics